Skip to main content
Log in

An ischemic β-dystroglycan (βDG) degradation: Correlation with irreversible injuiry in adult rabbit cardiomyocytes

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

A loss of sarcolemmal dystrophin was observed by immuno-fluorescence studies in rabbit hearts subjected to in situ myocardial ischemia and by immuno-blotting of the Triton soluble membrane fraction of isolated rabbit cardiomyocytes subjected to in vitro ischemia. This ischemic loss of dystrophin was a specific event in that no ischemic loss of sarcolemmal α-sarcoglycan, γ-sarcoglycan, αDG, or βDG was observed. The maintenance of sarcolemmal βDG (43 Kd) during ischemia was interesting in that dystrophin binds to the C-terminus of βDG. However, during late in vitro ischemia, a 30 Kd band was observed that was immuno-reactive for βDG. Additionally, this 30 Kd-βDG band was observed in rabbit myocardium subjected to autolysis. Finally, the 30 Kd-βDG was observed in the purified sarcolemmal fraction of rabbit cardiomyocytes subjected to a prolonged period of in vitro ischemia, confirming the sarcolemmal localization of this band. The potential patho-physiologic significance of this band was indicated by the appearance of this band at 120–180 min of in vitro ischemia, directly correlating with the onset of irreversible injury, as manifested by osmotic fragility. Additionally the appearance of this band was significantly reduced by the endogenous cardioprotective mechanism, in vitro ischemic preconditioning, which delays the onset of osmotic fragility. In addition to dystrophin, βDG binds caveolin-3 and Grb-2 at its C-terminus. The presence of Grb-2 and caveolin-3 in the membrane fractions of oxygenated and ischemic cardiomyocytes was determined by Western blotting. An increase in the level of membrane Grb-2 and caveolin-3 was observed following ischemic preconditioning as compared to control cells. The formation of this 30 Kd-βDG degradation product is potentially related to the transition from the reversible to the irreversible phase of myocardial ischemic cell injury and a decrease in 30 Kd-βDG might mediate the cardioprotection provided by ischemic preconditioning.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Sage MD, Jennings RB: Cytoskeletal injury and sub-sarcolemmal bleb formation in dog heart during in vitro total ischemia. Am J Pathol 133: 327-337, 1988

    Google Scholar 

  2. Steenbergen CJ, Hill ML, Jennings RB: Cytoskeletal damage during myocardial ischemia: Changes in vinculin immunofluorescence staining during total in vitro ischemia in canine heart. Circ Res 60: 478-486, 1987

    Google Scholar 

  3. Ganote CE, Vander Heide RS: Cytoskeletal lesions in anoxic myocardial injury: A conventional and high voltage electron microscopic and immunofluorescence study. Am J Pathol 129: 327-344, 1987

    Google Scholar 

  4. Steenbergen CJ, Hill ML, Jennings RB: Volume regulation and plasma membrane injury in aerobic, anaerobic and ischemic myocardium in vitro: Effect of osmotic swelling on plasma membrane integrity. Circ Res 57: 864-875, 1985

    Google Scholar 

  5. Tranum-Jensen J, Janse MJ, Fiolet JWT, Krieger JG, D'Alnoncourt CN, Durrer D: Tissue osmolality, cell swelling, and reperfusion in acute regional myocardial ischemia in the isolated porcine heart. Circ Res 49: 364-381, 1981

    Google Scholar 

  6. Armstrong SC, Shivell LC, Ganote CE: Sarcolemmal blebs and osmotic fragility as correlates of irreversible ischemic injury in preconditioned isolated rabbit cardiomyocytes. J Mol Cell Cardiol 33: 149-160, 2001

    Google Scholar 

  7. Ganote CE, Vander Heide RS: Irreversible injury of isolated adult rat myocytes: Osmotic fragility during metabolic inhibition. Am J Pathol 132: 212-222, 1988

    Google Scholar 

  8. Siegmund B, Koop A, Klietz T, Schwartz P, Piper HM: Sarcolemmal integrity and metabolic competence of cardiomyocytes under anoxia-reoxygenation. Am J Physiol 258 (Heart Circ Physiol 27): H285-H291, 1990

    Google Scholar 

  9. Buja LM, Willerson JT: Abnormalities of volume regulation and membrane integrity in myocardial tissue slices after early ischemic injury in the dog. Effects of mannitol, polyethylene glycol, and propranolol. Am J Pathol 103: 79-95, 1981

    Google Scholar 

  10. Di Stasio E, Sciandra F, Maras B, Di Tommaso F, Petrucci T, Giardina B, Branacaccio A: Structural and functional analysis of the N-terminal extracellular region of β-dystroglycan. Biochem Biophys Res Commun 266: 274-278, 1999

    Google Scholar 

  11. Jung D, Yang B, Meyer J, Chamberlain J, Campbell K: Identification and characterization of the dystrophin anchoring site on β-dystroglycan. J Biol Chem 270: 27305-27310, 1995

    Google Scholar 

  12. Stevenson S, Rothery S, Cullen MJ, Severs NJ: Spatial relationship of the C-terminal domains of dystrophin and β-dystroglycan in cardiac muscle support a direct molecular interaction at the plasma membrane interface. Circ Res 82: 82-93, 1998

    Google Scholar 

  13. Ohlendieck K: Towards an understanding of the dystrophin-glycoprotein complex: Linkage between the extracellular matrix and the membrane cytoskeleton in muscle fibers. Eur J Cell Biol 69: 1-10, 1996

    Google Scholar 

  14. Rentschler S, Linn H, Deininger K, Bedford M, Espanel X, Sudol M: The WW domain of dystrophin requires EF-hands region to interact with β-dystroglycan. Biol Chem 380: 431-442, 1999

    Google Scholar 

  15. James M, Nuttall A, Ilsley J, Ottersbach K, Tinsley J, Sudol M, Winder S: Adhesion-dependent tyrosine phosphorylation of β-dystroglycan regulates its interaction with utrophin. J Cell Sci 113: 1717-1726, 2000

    Google Scholar 

  16. Ilsley J, Sudol M, Winder S: The interaction of dystrophin with beta-dystroglycan is regulated by tyrosine phosphorylation. Cell Sig 13: 625-632, 2001

    Google Scholar 

  17. Sotgia F, Lee J, Das K, Bedford M, Petrucci T, Macioce P, Sargiacomo M, Bricarelli F, Minetti C, Sudol M, Lisanti M: Caveolin 3 directly interacts with the C-terminal tail of β-dystroglycan. Identification of a central WW-like domain within caveolin family members. J Biol Chem 275: 38048-38058, 2000

    Google Scholar 

  18. Russo K, Di Stasio E, Macchia G, Rosa G, Brancaccio A, Petrucci T: Characterization of the β-dystroglycan-growth factor receptor 2 (Grb2) interaction. Biochem Biophys Res Commun 274: 93-98, 2000

    Google Scholar 

  19. Venema V, Ju H, Zou R, Venema R: Interaction of neuronal nitric-oxide synthase with caveolin-3 in skeletal muscle: Identification of a novel caveolin scaffolding/inhibitory domain. J Biol Chem 272: 28187-28190, 1997

    Google Scholar 

  20. Li S, Couet J, Lisanti M: Src tyrosine kinases, Ga subunits and H-ras share a common membrane-anchored scaffolding protein, caveolin: Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J Biol Chem 271: 29182-29190, 1996

    Google Scholar 

  21. Calvadesi M, Macchia G, Barca S, Defilippi P, Tarone G, Petrucci T: Association of the dystroglycan complex isolated from bovine brain synaptosomes with proteins involved in signal transduction. J Neurochem 72: 1648-1655, 1999

    Google Scholar 

  22. Schlaepfer D, Hunter T: Evidence for in vivo phosphorylation of the Grb2 SH2-domain binding site on focal adhesion kinase by Src family protein-tyrosine kinases. Mol Cell Biol 16: 5623-5633, 1996

    Google Scholar 

  23. Armstrong S, Latham C, Shivell L, Ganote C: Ischemic loss of sarcolemmal dystrophin and spectrin: Correlation with myocardial injury. J Mol Cell Cardiol 33: 1165-1179, 2001

    Google Scholar 

  24. Losasso C, Di Tommaso F, Sgambato A, Ardito R, Cittadini A, Giardina B, Petrucci T, Brancaccio A: Anomalous dystroglycan in carcinoma cell lines. FEBS Lett 484: 194-198, 2000

    Google Scholar 

  25. Vander Heide RS, Angelo JP, Altschuld RA, Ganote CE: Energy dependence of contraction band formation in perfused hearts and isolated adult myocytes. Am J Pathol 125: 55-68, 1986

    Google Scholar 

  26. Hohl CM, Altschuld RA, Brierley GP: Effects of calcium on the permeability of isolated adult rat cells to sodium and potassium. Arch Biochem Biophys 221: 197-205, 1982

    Google Scholar 

  27. Armstrong SC, Ganote CE: Effects of 2,3-butanedione monoxime (BDM) on contracture and injury of isolated rat myocytes following metabolic inhibition and ischemia. J Mol Cell Cardiol 23: 1001-1014, 1991

    Google Scholar 

  28. Ohlendieck K, Ervasti JM, Snook JB, Campbell KP: Dystrophin-glycoprotein complex is highly enriched in isolated skeletal muscle sarcolemma. J Cell Biol 112: 135-148, 1991

    Google Scholar 

  29. Pelech SL, Meier KE, Krebs EG: Rapid microassay for protein kinase C translocation in Swiss 3T3 cells. Biochemistry 25: 8348-8353, 1986

    Google Scholar 

  30. Pereboev A, Ahmed N, thi Man N, Morris G: Epitopes in the interacting regions of β-dystroglycan (PPxY motif) and dystrophin (WW domain). Biochim Biophys Acta 1527: 54-60, 2001

    Google Scholar 

  31. Saito F, Masaki T, Kamakura K, Anderson LVB, Fujita S, Fukuta-Ohi H, Sunada Y, Shimizu T, Matsumara K: Characterization of the transmembrane molecular architecture of the dystroglycan complex in Schwann cells. J Biol Chem 274: 8240-8246, 1999

    Google Scholar 

  32. Anderson LVB, Davison K: Multiplex Western blotting system for the analysis of muscular dystrophy patients. Am J Pathol 154: 1017-1022, 1999

    Google Scholar 

  33. Armstrong SC, Delacey M, Ganote CE: Phosphorylation state of hsp27 and p38 MAPK during preconditioning and protein phosphatase inhibitor protection of rabbit cardiomyocytes. J Mol Cell Cardiol 31: 555-567, 1999

    Google Scholar 

  34. Armstrong SC, Shivell LC, Ganote CE: Differential translocation or phosphorylation of alpha B crystallin cannot be detected in ischemically preconditioned rabbit cardiomyocytes. J Mol Cell Cardiol 32: 1301-1314, 2000

    Google Scholar 

  35. Yamada H, Fumiaki S, Fukuta-Ohi H, Zhong D, Hase A, Arai K, Okuyama A, Maekawa R, Shimizu T, Matsumara K: Processing of β-dystroglycan by matrix metalloproteinase disrupts the link between the extracellular matrix and cell membrane via the dystroglycan complex. Hum Mol Genet 10: 1563-1569, 2001

    Google Scholar 

  36. Herdson P, Kaltenbach J, Jennings R: Fine structural and biochemical changes in dog myocardium during autolysis. Am J Pathol 57: 539-557, 1969

    Google Scholar 

  37. Sage MD, Jennings RB: Subplasmalemmal leptomeres in adult canine myocytes: Putative cytoskeletal function and the effect of total in vitro ischemia. Lab Invest 61: 171-176, 1989

    Google Scholar 

  38. Yang B, Jung D, Motto D, Meyer J, Koretzky G, Campbell K: SH3 domain-mediated interaction of dystroglycan and Grb2. J Biol Chem 270: 11711-11714, 1995

    Google Scholar 

  39. Diaz RJ, Losito VA, Mao GD, Ford MK, Backx PH, Wilson GL: Chloride channel inhibition blocks the protection of ischemic preconditioning and hypo-osmotic stress in rabbit ventricular myocardium. Circ Res 84: 763-775, 1999

    Google Scholar 

  40. Seko Y, Takahashi N, Sabe H, Tobe K: Hypoxia induces activation and subcellular translocation of focal adhesion kinase (p125FAK) in cultured rat cardiac myocytes. Biochem Biophys Res Commun 262: 290-296, 1999

    Google Scholar 

  41. Lepple-Wienhues A, Szabo I, Laun T, Kaba N, Gulbins E, Lang F: The tyrosine kinase p561ck mediates activation of swelling induced chloride channels in lymphocytes. J Cell Biol 141: 281-286, 1998

    Google Scholar 

  42. Ping P, Zhang J, Zheng Y, Li R, Dawn B, Tang X, Takano H, Balafanova Z, Bolli R: Demonstration of selective protein kinase C dependent activation of Src and Lck tyrosine kinases during ischemic preconditioning in conscious rabbits. Circ Res 85: 542-550, 1999

    Google Scholar 

  43. Sotgia F, Lee H, Bedford MT, Petrucci T, Sudol M, Lisanti MP: Tyrosine phosphorylation of β-dystroglycan at its WW domain binding motif, PPxY, recruits SH2 domain containing proteins. Biochemistry 40: 14585-14592, 2001

    Google Scholar 

  44. Sada K, Minami Y, Yamamura H: Relocation of Syk protein tyrosine kinase to the actin filament network and subsequent association with Fak. Eur J Biochem 248: 827-833, 1997

    Google Scholar 

  45. Couture C, Baier G, Oetken C, Williams S, Telford D, Marie-Cardine A, Baier-Bitterlich G, Fischer S, Burn P, AA: Activation of p56lck by p72syk through physical association and N-terminal tyrosine phosphorylation. Mol Cell Biol 14: 5249-5258, 1994

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Armstrong, S.C., Latham, C.A. & Ganote, C.E. An ischemic β-dystroglycan (βDG) degradation: Correlation with irreversible injuiry in adult rabbit cardiomyocytes. Mol Cell Biochem 242, 71–79 (2003). https://doi.org/10.1023/A:1021185627968

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1021185627968

Navigation